Notice of Interim Results

Summary by AI BETAClose X

Avacta Group PLC will announce its unaudited interim results for the six months ended June 30, 2025, on September 30, 2025, and will deliver a live presentation via Investor Meet Company at 14:00 BST on the same day. The company also confirmed a change to the date, time, and location for the presentation of its abstract at the European Society for Medical Oncology (ESMO) Congress. The presentation, titled "A Phase I trial of FAP-Dox (AVA6000)..." with abstract number 964P, will now take place on October 19 at 12:00-12:45 in Hall 25.

Disclaimer*

UK 100

Latest directors dealings